FindTrial
Sign In

Examination of the usefulness of Basophil activation test (BAT) to L-asparaginase hypersensitivity reaction

Examination of the usefulness of Basophil activation test (BAT) to L-asparaginase hypersensitivity reaction - L-asparaginase hypersensitivity reaction and BAT

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000008715
Enrollment
60
Registered
2012-08-17
Start date
2012-07-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute lymphoblastic leukemia lymphoma

Interventions

None listed

Sponsors

Department of pediatrics, St.marianna University school of Medicine Hospital
Lead Sponsor
Department of pediatrics, Yokohama City University Hospital Department of pediatrics, Showa University Fujigaoka Hospital Kanagawa Children`s Medical Center
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient of acute lymphoblastic leukemia and lymphoma that received L-asparaginase, And a legal proxy agreed in St. Marianna University School of Medicine Hospital or collaboration institution.

Exclusion criteria

Exclusion criteria: There are not the exclusion criteria in particular.

Design outcomes

Primary

MeasureTime frame
In having L-asparaginase hypersensitivity reaction or not, Basophil activation test (BAT) Drug-induced lymphocyte stimulation test (DLST)—

Countries

Japan

Contacts

Public ContactDai Keino

St.marianna University school of Medicine Hospital Department of pediatrics

d2keino@marianna-u.ac.jp044-977-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026